tweenvest

Belite Bio, Inc (NasdaqGS: BLTE)

Health Care · Pharmaceuticals · US

$169.96

+8.99% today · +51.2% 1Y

Public summary
A free snapshot of Belite Bio, Inc, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Belite Bio, Inc (NasdaqGS: BLTE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.84B and employs 41 people.

Over the last twelve months the share price has gained 51.2%, trading between 105.88 and 200.00.

Tweenvest scores Belite Bio, Inc across four factors: quality 41/100, value 76/100. Its strongest factor is value.

BLTE price history

Nov 21, 2025 · 120.56Weekly closes 120.56 – 193.61Nov 12, 2026 · 169.96

Key figures

Market cap
$6.84B
Revenue (TTM)
—
P/E
-61.69
EPS
-2.83
Dividend yield
—
Beta (5Y)
-1.19
52-week high
$200.00
52-week low
$105.88
Avg volume (3M)
—
Shares outstanding
40.27M
Employees
41
Next earnings
—

About Belite Bio, Inc

Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical trials, LBS-008 is engineered to modulate vitamin A delivery to the eye, thus preventing the accumulation of detrimental vitamin A metabolites in ocular tissues. Furthermore, Belite Bio is advancing LBS-009, an oral anti-retinol binding protein 4 therapy, through preclinical development. This therapy targets various liver ailments, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Founded in 2016, Belite Bio, Inc. is headquartered in San Diego, California, and operates as a subsidiary of Lin Bioscience International Ltd.

ISIN
US07782B1044
Founded
2016
Listed since
Apr 29, 2022
Exchange
Nasdaq Global Select
Currency
USD
CompanyMarket capPriceDay
ABIVAX Société AnonymeENXTPA: ABVX$7.33B€76.65+1.52%
Gedeon Richter PLCBUSE: RICHTER$7.32BFt13,500.00-0.74%
CSPC Innovation Pharmaceutical Co., Ltd.SZSE: 300765$7.17BCN¥34.36-2.86%
Axsome Therapeutics, Inc.NasdaqGM: AXSM$7.05B$134.00-1.43%
Alkem Laboratories LimitedNSEI: ALKEM$6.68BRs5,222.50+0.92%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.SZSE: 000999$6.59BCN¥26.40-0.04%
Apotex Health Corp.TSX: APTX$6.45BCA$40.28+2.13%
Ligand Pharmaceuticals IncorporatedNasdaqGM: LGND$6.33B$316.27-0.18%

Browse every Pharmaceuticals company →